Enveric Biosciences, Inc.

ENVB · Nasdaq · SIC 2834: Pharmaceutical Preparations
476
SEC Filings

Business Summary

Enveric Biosciences, Inc. is a biotechnology company focused on developing next-generation, small-molecule neuroplastogenic therapeutics for psychiatric and neurological disorders. Its lead candidate, EB-003, a novel DMT derivative, is designed to selectively engage 5-HT2A and 5-HT1B receptors to deliver antidepressant and anxiolytic effects without hallucinogenic properties. The company leverages a proprietary drug discovery platform and patent-protected chemical library (Psybrary) to advance non-hallucinogenic psychedelic-inspired compounds through preclinical and clinical development.

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionENVBdiscussed_in_filing Artificial Intelligence
topic_mentionENVBdiscussed_in_filing Cybersecurity
topic_mentionENVBdiscussed_in_filing Trusted Computing
topic_mentionENVBdiscussed_in_filing Blockchain & Crypto
topic_mentionENVBdiscussed_in_filing Regulation
topic_mentionENVBdiscussed_in_filing Healthcare & Bio
topic_mentionENVBdiscussed_in_filing Platform & Ecosystem
topic_mentionENVBdiscussed_in_filing Sovereign & Government
topic_mentionENVBdiscussed_in_filing Artificial Intelligence
topic_mentionENVBdiscussed_in_filing Cybersecurity
topic_mentionENVBdiscussed_in_filing Trusted Computing
topic_mentionENVBdiscussed_in_filing Blockchain & Crypto
topic_mentionENVBdiscussed_in_filing Regulation
topic_mentionENVBdiscussed_in_filing Healthcare & Bio
topic_mentionENVBdiscussed_in_filing Platform & Ecosystem
topic_mentionENVBdiscussed_in_filing Sovereign & Government
topic_mentionENVBdiscussed_in_filing Artificial Intelligence
topic_mentionENVBdiscussed_in_filing Cybersecurity
topic_mentionENVBdiscussed_in_filing Trusted Computing
topic_mentionENVBdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001493152-26-013294EDGAR67K words
2025-03-282024-12-310001641172-25-001296EDGAR—
2024-03-262023-12-310001493152-24-011210EDGAR—
2023-03-312022-12-310001493152-23-010431EDGAR—
2022-03-312021-12-310001493152-22-008510EDGAR—
2021-04-012020-12-310001493152-21-007757EDGAR—
2020-03-252019-12-310001140361-20-006825EDGAR—
2019-03-262018-12-310001140361-19-005573EDGAR—
2018-04-022017-12-310001140361-18-016275EDGAR—
2017-03-312016-12-310001079974-17-000125EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001493152-25-023540EDGAR18K words
2025-08-142025-06-300001641172-25-024021EDGAR—
2025-05-142025-03-310001641172-25-010345EDGAR—
2024-11-142024-09-300001493152-24-045859EDGAR—
2024-08-122024-06-300001493152-24-031352EDGAR—
2024-05-152024-03-310001493152-24-019364EDGAR—
2023-11-132023-09-300001493152-23-040493EDGAR—
2023-08-112023-06-300001493152-23-027881EDGAR—
2023-05-152023-03-310001493152-23-016990EDGAR—
2022-11-142022-09-300001493152-22-032131EDGAR—
2022-08-122022-06-300001493152-22-022369EDGAR—
2022-05-132022-03-310001493152-22-013332EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001493152-26-013290EDGAR2K words
2026-02-060001493152-26-005606EDGAR—
2026-01-280001493152-26-004055EDGAR—
2026-01-090001493152-26-001151EDGAR—
2025-12-120001493152-25-027541EDGAR—
2025-12-110001493152-25-027196EDGAR—
2025-11-140001493152-25-023444EDGAR—
2025-11-140001493152-25-023441EDGAR—
2025-10-230001493152-25-019095EDGAR—
2025-09-180001493152-25-014073EDGAR—

476 total filings indexed. 444 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

psychiatric-disorders neurological-disorders depression-treatment anxiety-treatment addiction-treatment central-nervous-system-therapeutics

Company Identity

CIK0000890821
TickerENVB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersCambridge, MA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 83aaa69b84fdde4ce15286d6bd6060ff99ec2afaa040b9b4a90e54cf7f3b3eb2
parent: d21acbfdeaeee65a3349b0907ea83a5b8b597989e0a1d4beed47c38f0f30f4ab
content hash: c6cdeef91446cc5abd0154b63f05ccb231d320f21ffa57e1c81aa94654083439
signed: 2026-04-13T04:44:52.375Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf